德克-1通过诱导微质介导的炎症和血视网膜屏障的破坏驱动糖尿病视网膜病变
Lei Zhang1,2, Sumei Zhang3, Yingjun Li2
1Department of Ophthalmology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Developmental neurobiology
|August 12, 2025
概括
在糖尿病视网膜病变 (DR) 中,Dectin-1的表达很高. 在DR模型中,用拉米纳林 (LAM) 抑制Dectin-1可降低炎症并保护视网膜血液屏障 (BRB).
科学领域:
- 免疫学 免疫学 免疫学
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病视网膜病变 (DR) 是糖尿病患者视力丧失的主要原因.
- 德克-1是一种先天性免疫受体,在糖尿病中起作用.
- 德克-1在DR病变发生中的作用尚不清楚.
研究的目的:
- 研究Dectin-1在糖尿病视网膜病变中的作用.
- 评估DR中Dectin-1抑制的治疗潜力.
主要方法:
- 已建立的糖尿病小鼠模型使用链毒素 (STZ) 和在人微质细胞 (HMC3) 上高葡萄糖 (HG) 的体外模型.
- 通过RT-qPCR和西式涂抹评估Dectin-1表达.
- 使用RT-qPCR,ELISA,免疫光和TUNEL分析测量了炎症标志物,视网膜屏障 (BRB) 完整性和亡.
主要成果:
- 在糖尿病小鼠的视网膜组织和暴露于HG的HMC3细胞中,dectin-1的表达显著上调.
- 德克丁-1抗剂拉米纳林 (LAM) 抑制了微质激活,炎症和BRB泄漏在体外和体内.
- 在体内,LAM显示出抗亡作用.
结论:
- 德克-1与糖尿病视网膜病变的发病有关.
- 抑制德-1是一种潜在的治疗策略,可以通过减轻炎症和保持BRB完整性来保护DR相关的视力损失.
相关概念视频
Type I Diabetes I: Introduction
89
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
89
Type I Diabetes II: Pathophysiology
122
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
122
Diabetic Retinopathy
66
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
66
Diabetic Nephropathy
52
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
52
Diabetic Neuropathy
99
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
99
Inflammatory Bowel Disease III: Crohn's Disease
75
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
75


